Fundraising FoxCatamaran Bio
3 known investors
Find your way into Catamaran Bio
Sign up to see every warm intro you have to Catamaran Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Catamaran Bio team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Catamaran Bio develops allogeneic CAR-NK cell therapies for cancer treatment, focusing on solid tumors, by combining natural killer (NK) cell biology with synthetic biology and non-viral cell engineering. Its proprietary TAILWIND platform is used to engineer, expand, and process NK cells into cell therapy products.
Founders & leadership
Investors · 3
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ANov 2020Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Catamaran Bio went on to found or lead other companies.
Frequently asked questions
- What does Catamaran Bio do?
- Catamaran Bio develops allogeneic CAR-NK cell therapies for cancer treatment, focusing on solid tumors, by combining natural killer (NK) cell biology with synthetic biology and non-viral cell engineering. Its proprietary TAILWIND platform is used to engineer, expand, and process NK cells into cell therapy products.
- Who founded Catamaran Bio?
- Catamaran Bio was founded by Branden Moriarity, Catherine Bollard.
- Who are Catamaran Bio's investors?
- Catamaran Bio's investors include Astellas Venture Management LLC, Sofinnova Partners, Lightstone Ventures.